Preventing ATP Degradation by ASO-Mediated Knockdown of CD39 and CD73 Results in A2aR-Independent Rescue of T Cell Proliferation
The adenosine axis contributes to the suppression of antitumor immune responses. The ectonucleotidase CD39 degrades extracellular adenosine triphosphate (ATP) to adenosine monophosphate (AMP), which is degraded to adenosine by CD73. Adenosine binds to, e.g., the A2a receptor (A2aR), which reportedly...
Saved in:
Main Authors: | Julia Festag (Author), Tamara Thelemann (Author), Monika Schell (Author), Stefanie Raith (Author), Sven Michel (Author), Frank Jaschinski (Author), Richard Klar (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CD39 and CD73 as Promising Therapeutic Targets: What Could Be the Limitations?
by: Ana Maria Oliveira Battastini, et al.
Published: (2021) -
Exploring CD39 and CD73 Expression as Potential Biomarkers in Prostate Cancer
by: Carla Fernanda Furtado Gardani, et al.
Published: (2023) -
Nucleotide Analog ARL67156 as a Lead Structure for the Development of CD39 and Dual CD39/CD73 Ectonucleotidase Inhibitors
by: Laura Schäkel, et al.
Published: (2020) -
High Expression of Ecto-Nucleotidases CD39 and CD73 in Human Endometrial Tumors
by: Elisabet Aliagas, et al.
Published: (2014) -
Cytokine-Induced Killer Cells Express CD39, CD38, CD203a, CD73 Ectoenzymes and P1 Adenosinergic Receptors
by: Alberto L. Horenstein, et al.
Published: (2018)